Literature DB >> 19047917

Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation.

Troy D Pashuck1, Sarah E Franz, Molly K Altman, Clive H Wasserfall, Mark A Atkinson, Thomas J Wronski, Terence R Flotte, Michael S Stalvey.   

Abstract

As the incidence of cystic fibrosis (CF) bone disease is increasing, we analyzed CF transmembrane conductance regulator (CFTR) deficient mice (CF mice) to gain pathogenic insights. In these studies comparing adult (14 wk) CF and C57BL/6J mice, both bone length and total area were decreased in CF mice. Metaphyseal trabecular and cortical density were also decreased, as well as diaphyseal cortical and total density. Trabecular bone volume was diminished in CF mice. Female CF mice revealed decreased trabecular width and number compared with C57BL/6J, whereas males demonstrated no difference in trabecular number. Female CF mice had reduced mineralizing surface and bone formation rates. Conversely, male CF mice had increased mineralizing surface, mineral apposition, and bone formation rates compared with C57BL/6J males. Bone formation rate was greater in males compared with female CF mice. Smaller bones with decreased density in CF, despite absent differences in osteoblast and osteoclast surfaces, suggest CF transmembrane conductance regulator influences bone cell activity rather than number. Differences in bone formation rate in CF mice are suggestive of inadequate bone formation in females but increased bone formation in males. This proanabolic observation in male CF mice is consistent with other clinical sex differences in CF.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19047917      PMCID: PMC4201032          DOI: 10.1203/PDR.0b013e3181961e80

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  44 in total

1.  Sternal fracture with fatal outcome in cystic fibrosis.

Authors:  P Latzin; M Griese; V Hermanns; B Kammer
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

2.  Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency.

Authors:  Yan Xu; Jean C Clark; Bruce J Aronow; Chitta R Dey; Cong Liu; Jamie L Wooldridge; Jeffrey A Whitsett
Journal:  J Biol Chem       Date:  2002-12-12       Impact factor: 5.157

3.  Mild to moderate cystic fibrosis is not associated with increased fracture risk in children and adolescents.

Authors:  Alisha J Rovner; Babette S Zemel; Mary B Leonard; Joan I Schall; Virginia A Stallings
Journal:  J Pediatr       Date:  2005-09       Impact factor: 4.406

4.  Growth hormone treatment enhances nutrition and growth in children with cystic fibrosis receiving enteral nutrition.

Authors:  Dana S Hardin; Julie Rice; Chul Ahn; Thomas Ferkol; Michelle Howenstine; Stacey Spears; Claude Prestidge; Dan K Seilheimer; Ross Shepherd
Journal:  J Pediatr       Date:  2005-03       Impact factor: 4.406

5.  Severe osteopenia in CFTR-null mice.

Authors:  Fariel Dif; Caroline Marty; Claude Baudoin; Marie-Christine de Vernejoul; Giovanni Levi
Journal:  Bone       Date:  2004-09       Impact factor: 4.398

6.  Prevalence and correlates of vertebral fractures in adults with cystic fibrosis.

Authors:  M Rossini; A Del Marco; F Dal Santo; D Gatti; C Braggion; G James; S Adami
Journal:  Bone       Date:  2004-09       Impact factor: 4.398

7.  Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients.

Authors:  Hara Levy; Leslie A Kalish; Carolyn L Cannon; K Christopher García; Craig Gerard; Don Goldmann; Gerald B Pier; Scott T Weiss; A A Colin
Journal:  Pediatr Pulmonol       Date:  2008-05

8.  Unraveling estrogen action in osteoporosis.

Authors:  Susan A Krum; Myles Brown
Journal:  Cell Cycle       Date:  2008-02-29       Impact factor: 4.534

9.  Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone.

Authors:  Elizabeth F Shead; Charles S Haworth; Alison M Condliffe; Damian J McKeon; Mike A Scott; Juliet E Compston
Journal:  Thorax       Date:  2007-07       Impact factor: 9.139

10.  Aggresomes: a cellular response to misfolded proteins.

Authors:  J A Johnston; C L Ward; R R Kopito
Journal:  J Cell Biol       Date:  1998-12-28       Impact factor: 10.539

View more
  14 in total

1.  Pigs and humans with cystic fibrosis have reduced insulin-like growth factor 1 (IGF1) levels at birth.

Authors:  Mark P Rogan; Leah R Reznikov; Alejandro A Pezzulo; Nicholas D Gansemer; Melissa Samuel; Randall S Prather; Joseph Zabner; Douglas C Fredericks; Paul B McCray; Michael J Welsh; David A Stoltz
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

Review 2.  Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.

Authors:  J Jacquot; M Delion; S Gangloff; J Braux; F Velard
Journal:  Osteoporos Int       Date:  2015-10-02       Impact factor: 4.507

3.  CFTR induces extracellular acid sensing in Xenopus oocytes which activates endogenous Ca²⁺-activated Cl⁻ conductance.

Authors:  Patthara Kongsuphol; Rainer Schreiber; Kamonshanok Kraidith; Karl Kunzelmann
Journal:  Pflugers Arch       Date:  2011-06-07       Impact factor: 3.657

4.  Cystic fibrosis growth retardation is not correlated with loss of Cftr in the intestinal epithelium.

Authors:  Craig A Hodges; Brian R Grady; Kirtishri Mishra; Calvin U Cotton; Mitchell L Drumm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-09       Impact factor: 4.052

5.  Increased NF-κB Activity and Decreased Wnt/β-Catenin Signaling Mediate Reduced Osteoblast Differentiation and Function in ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mice.

Authors:  Carole Le Henaff; Rafik Mansouri; Dominique Modrowski; Mylène Zarka; Valérie Geoffroy; Caroline Marty; Nadine Tarantino; Emmanuel Laplantine; Pierre J Marie
Journal:  J Biol Chem       Date:  2015-06-09       Impact factor: 5.157

6.  Children and adolescents with cystic fibrosis display moderate bone microarchitecture abnormalities: data from high-resolution peripheral quantitative computed tomography.

Authors:  C Braun; J Bacchetta; P Braillon; R Chapurlat; J Drai; P Reix
Journal:  Osteoporos Int       Date:  2017-08-09       Impact factor: 4.507

Review 7.  Cystic fibrosis-related bone disease: insights into a growing problem.

Authors:  Michael S Stalvey; Gregory A Clines
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2013-12       Impact factor: 3.243

8.  Sex differences impact the lung-bone inflammatory response to repetitive inhalant lipopolysaccharide exposures in mice.

Authors:  Amy J Nelson; Shyamal K Roy; Kristi Warren; Katherine Janike; Geoffrey M Thiele; Ted R Mikuls; Debra J Romberger; Dong Wang; Benjamin Swanson; Jill A Poole
Journal:  J Immunotoxicol       Date:  2018-12       Impact factor: 3.000

9.  Growth failure and treatment in cystic fibrosis.

Authors:  Trang N Le; Abeer Anabtawi; Melissa S Putman; Vin Tangpricha; Michael S Stalvey
Journal:  J Cyst Fibros       Date:  2019-10       Impact factor: 5.482

10.  The Effects of Ivacaftor on Bone Density and Microarchitecture in Children and Adults with Cystic Fibrosis.

Authors:  Melissa S Putman; Logan B Greenblatt; Michael Bruce; Taisha Joseph; Hang Lee; Gregory Sawicki; Ahmet Uluer; Leonard Sicilian; Isabel Neuringer; Catherine M Gordon; Mary L Bouxsein; Joel S Finkelstein
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.